approval
saveDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 2 initiationNational Cancer Institute US — (daratumumab + hyaluronidase (human recombinant)) (Phase II Trial Initiation)Apr 29, 2026 · 158d ago
- approvalDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalFeb 12, 2026 · 234d ago
- approvalDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalJan 27, 2026 · 250d ago
- approvalDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 19, 2025 · 319d ago
- approvalDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 14, 2025 · 324d ago
- approvalDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 6, 2025 · 332d ago
- approvalDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalJul 30, 2024 · 796d ago
- approvalDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 2, 2022 · 1432d ago
same company · ±60 days · 6
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalJan 11, 2021
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalFeb 8, 2021
- approvalustekinumab: STELARA (USTEKINUMAB) — FDA approvalDec 11, 2020
- approvalustekinumab: STELARA (USTEKINUMAB) — FDA approvalDec 1, 2020
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalMar 12, 2021
- approvalapalutamide: ERLEADA (APALUTAMIDE) — FDA approvalNov 20, 2020
🐶 often sniffed alongside
top 8- drugdaratumumab31 co-mentions · 16 sources
- drugdaratumumab + Gene Therapy31 co-mentions · 16 sources
- drugDARZALEX FASPRO30 co-mentions · 15 sources
- tagApproval30 co-mentions · 15 sources
- companyJanssen Biotech Inc15 co-mentions · 15 sources
- tagOncology2 co-mentions · 1 sources
- tagMultiple Myeloma2 co-mentions · 1 sources
- companyNational Cancer Institute US1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that